|
1
|
MacDonald KV, Sanmartin C, Langlois K and
Marshall DA: Symptom onset, diagnosis and management of
osteoarthritis. Health Rep. 25:10–17. 2014.PubMed/NCBI
|
|
2
|
Chu CR, Millis MB and Olson SA:
Osteoarthritis: From Palliation to Prevention: AOA Critical Issues.
J Bone Joint Surg Am. 96:e1302014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hare KB, Lohmander Stefan L, Kise NJ,
Risberg MA and Roos EM: Middle-aged patients with an MRI-verified
medial meniscal tear report symptoms commonly associated with knee
osteoarthritis. Acta Orthop. 88:664–669. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Guermazi A, Roemer FW, Haugen IK, Crema MD
and Hayashi D: MRI-based semiquantitative scoring of joint
pathology in osteoarthritis. Nat Rev Rheumatol. 9:236–251. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghavipour M, Sotoudeh G, Tavakoli E, Mowla
K, Hasanzadeh J and Mazloom Z: Pomegranate extract alleviates
disease activity and some blood biomarkers of inflammation and
oxidative stress in rheumatoid arthritis patients. Eur J Clin Nutr.
71:92–96. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Helgesson L, Johansson PK, Aurell Y,
Tiderius CJ, Kärrholm J and Riad J: Early osteoarthritis after
slipped capital femoral epiphysis. Acta Orthop. 89:222–228. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Park YM, Kim SJ, Lee KJ, Yang SS, Min BH
and Yoon HC: Detection of CTX-II in serum and urine to diagnose
osteoarthritis by using a fluoro-microbeads guiding chip. Biosens
Bioelectron. 67:192–199. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karalilova R, Kazakova M, Batalov A and
Sarafian V: Correlation between protein YKL-40 and ultrasonographic
findings in active knee osteoarthritis. Med Ultrason. 1:57–63.
2018. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Bruyere O, Collette J, Kothari M, Zaim S,
White D, Genant H, Peterfy C, Burlet N, Ethgen D, Montague T, et
al: Osteoarthritis, magnetic resonance imaging, and biochemical
markers: A one year prospective study. Ann Rheum Dis. 65:1050–1054.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kongtharvonskul J, Woratanarat P, McEvoy
M, Attia J, Wongsak S, Kawinwonggowit V and Thakkinstian A:
Efficacy of glucosamine plus diacerein versus monotherapy of
glucosamine: A double-blind, parallel randomized clinical trial.
Arthritis Res Ther. 18:2332016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bellamy N, Buchanan WW, Goldsmith CH,
Campbell J and Stitt LW: Validation study of WOMAC: A health status
instrument for measuring clinically important patient relevant
outcomes to antirheumatic drug therapy in patients with
osteoarthritis of the hip or knee. J Rheumatol. 15:1833–1840.
1988.PubMed/NCBI
|
|
12
|
Hunter AM, Leuchter AF, Cook IA, Abrams M,
Siegman BE, Furst DE and Chappell AS: Brain functional changes and
duloxetine treatment response in fibromyalgia: A pilot study. Pain
Med. 10:730–738. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mazzuca SA, Brandt KD, Schauwecker DS,
Katz BP, Meyer JM, Lane KA, Bradley JD, Hugenberg ST, Wolfe F,
Moreland LW, et al: Severity of joint pain and Kellgren-Lawrence
grade at baseline are better predictors of joint space narrowing
than bone scintigraphy in obese women with knee osteoarthritis. J
Rheumatol. 32:1540–1546. 2005.PubMed/NCBI
|
|
14
|
Pavelká K, Gatterová J, Olejarová M,
Machacek S, Giacovelli G and Rovati LC: Glucosamine sulfate use and
delay of progression of knee osteoarthritis: A 3-year, randomized,
placebo-controlled, double-blind study. Arch Intern Med.
162:2113–2123. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pavelka K, Trc T, Karpas K, Vítek P,
Sedlácková M, Vlasáková V, Böhmová J and Rovenský J: The efficacy
and safety of diacerein in the treatment of painful osteoarthritis
of the knee: A randomized, multicenter, double-blind,
placebo-controlled study with primary end points at two months
after the end of a three-month treatment period. Arthritis Rheum.
56:4055–4064. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Park G, Horie T, Fukasawa K, Ozaki K,
Onishi Y, Kanayama T, Iezaki T, Kaneda K, Sugiura M and Hinoi E:
Amelioration of the development of osteoarthritis by daily intake
of β-cryptoxanthin. Biol Pharm Bull. 40:1116–1120. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shirakura M, Kram V, Robinson J, Sikka S,
Kilts TM, Wadhwa S and Young MF: Extracellular matrix mediates
BMP-2 in a model of temporomandibular joint osteoarthritis. Cells
Tissues Organs. 204:84–92. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yamamoto K, Santamaria S, Botkjaer KA,
Dudhia J, Troeberg L, Itoh Y, Murphy G and Nagase H: Inhibition of
shedding of low-density lipoprotein receptor-related protein 1
reverses cartilage matrix degradation in osteoarthritis. Arthritis
Rheumatol. 69:1246–1256. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ok SM, Lee SM, Park HR, Jeong SH, Ko CC
and Kim YI: Concentrations of CTX I, CTX II, DPD, and PYD in the
urine as a biomarker for the diagnosis of temporomandibular joint
osteoarthritis: A preliminary study. Cranio. 36:366–372.
2018.PubMed/NCBI
|
|
20
|
Duclos ME, Roualdes O, Cararo R, Rousseau
JC, Roger T and Hartmann DJ: Significance of the serum CTX-II level
in an osteoarthritis animal model: A 5-month longitudinal study.
Osteoarthritis Cartilage. 18:1467–1476. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dündar Ü, Aşık G, Ulaşlı AM, Sınıcı Ş,
Yaman F, Solak Ö, Toktaş H and Eroğlu S: Assessment of pulsed
electromagnetic field therapy with Serum YKL-40 and ultrasonography
in patients with knee osteoarthritis. Int J Rheum Dis. 19:287–293.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Väänänen T, Vuolteenaho K, Kautiainen H,
Nieminen R, Möttönen T, Hannonen P, Korpela M, Kauppi MJ, Laiho K,
Kaipiainen-Seppänen O, et al: NEO-RACo Study Group: Glycoprotein
YKL-40: A potential biomarker of disease activity in rheumatoid
arthritis during intensive treatment with csDMARDs and infliximab.
Evidence from the randomised controlled NEO-RACo trial. PLoS One.
12:e01832942017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Meulenbelt I, Kloppenburg M, Kroon HM,
Houwing-Duistermaat JJ, Garnero P, Hellio Le, Graverand MP, Degroot
J and Slagboom PE: Urinary CTX-II levels are associated with
radiographic subtypes of osteoarthritis in hip, knee, hand, and
facet joints in subject with familial osteoarthritis at multiple
sites: The GARP study. Ann Rheum Dis. 65:360–365. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Väänänen T, Koskinen A, Paukkeri EL,
Hämäläinen M, Moilanen T, Moilanen E and Vuolteenaho K: YKL-40 as a
novel factor associated with inflammation and catabolic mechanisms
in osteoarthritic joints. Mediators Inflamm. 2014:2151402014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pavelka K, Bruyère O, Cooper C, Kanis JA,
Leeb BF, Maheu E, Martel-Pelletier J, Monfort J, Pelletier JP,
Rizzoli R, et al: Erratum to: Diacerein: benefits, risks and place
in the management of Osteoarthritis. An opinion-based report from
the ESCEO. Drugs Aging. 34:4132017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Roman-Blas JA, Castañeda S,
Sánchez-Pernaute O, Largo R and Herrero-Beaumont G: CS/GS Combined
Therapy Study Group: Combined treatment with chondroitin sulfate
and glucosamine sulfate shows no superiority over placebo for
reduction of joint pain and functional impairment in patients with
knee osteoarthritis: A six-month multicenter, randomized,
double-blind, placebo-controlled clinical trial. Arthritis
Rheumatol. 69:77–85. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wen ZH, Tang CC, Chang YC, Huang SY, Hsieh
SP, Lee CH, Huang GS, Ng HF, Neoh CA, Hsieh CS, et al: Glucosamine
sulfate reduces experimental osteoarthritis and nociception in
rats: association with changes of mitogen-activated protein kinase
in chondrocytes. Osteoarthritis Cartilage. 18:1192–1202. 2012.
View Article : Google Scholar
|
|
28
|
Wilkens P, Scheel IB, Grundnes O, Hellum C
and Storheim K: Effect of glucosamine on pain-related disability in
patients with chronic low back pain and degenerative lumbar
osteoarthritis: a randomized controlled trial. JAMA. 304:45–52.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pelletier JP, Yaron M, Haraoui B, Cohen P,
Nahir MA, Choquette D, Wigler I, Rosner IA and Beaulieu AD: The
Diacerein Study Group: Efficacy and safety of diacerein in
osteoarthritis of the knee: A double-blind, placebo-controlled
trial. Arthritis Rheum. 43:2339–2348. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Manicourt DH, Azria M, Mindeholm L, Thonar
EJ and Devogelaer JP: Oral salmon calcitonin reduces Lequesne's
algofunctional index scores and decreases urinary and serum levels
of biomarkers of joint metabolism in knee osteoarthritis. Arthritis
Rheum. 54:3205–3211. 2006. View Article : Google Scholar : PubMed/NCBI
|
